MRVI vs NBIX · rev $117.3M vs P/E 45, rev $1.77B
Maravai Lifesciences Holdings Inc (MRVI) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
MRVI currently screens at market cap $1.93B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the MRVI and NBIX stock pages for the full models.
Not investment advice.